Established in 2016 and based in India, Genes2Me is a pioneer manufacturer of the most promising and unfaltering in vitro diagnostic solutions. We are recognized for providing the most robust and cost-effective solutions across the globe bringing impactful changes in the diagnostic and patient care industry.
Our product portfolio includes molecular Next Generation Sequencing (NGS) clinical panels, point-of-care (POC) testing solutions, RT-PCR kits and instruments, rapid antigen/antibody testing kits, and molecular biology reagents. All our solutions are CE-IVD marked assuring our clients of unparalleled quality and compliance with international standards.
OnePCR device is our trailblazing invention which allows automated nucleic acid extraction and RT-PCR testing together, to detect up to 16 targets from a single sample. We offer the most comprehensive NGS clinical panels menu complemented with an automated cloud-based data analysis software Interpreter.
We at Genes2Me have been working tirelessly to innovate exceptional diagnostic solutions and make them accessible across the world.
